Skip to content
ppharmaranks
Menu

Best Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor for aids-related opportunistic infections

Top-rated pick: Valganciclovir Hydrochloride — pharmaranks score 70/100, the highest of the 3 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor drugs used for aids-related opportunistic infections, ranked by our independent FDA recall-safety score. Compare them with all treatments for aids-related opportunistic infections or the full Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 3 cytomegalovirus nucleoside analog dna polymerase inhibitor drugs we rate for aids-related opportunistic infections, 2 are available as lower-cost generics, and most are solution. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for aids-related opportunistic infections; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top cytomegalovirus nucleoside analog dna polymerase inhibitor for aids-related opportunistic infections: 1. Valganciclovir Hydrochloride · 2. Valcyte · 3. Zirgan

Best-rated Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor for aids-related opportunistic infections, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$56View →
2Not yet rated$56View →
3Not yet ratedView →

Full ranking · 3 drugs

Frequently asked

What is the best cytomegalovirus nucleoside analog dna polymerase inhibitor for aids-related opportunistic infections?
By our independent recall-safety rating — not an efficacy measure — valganciclovir hydrochloride ranks highest among Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor drugs used for aids-related opportunistic infections. Always consult a professional.
Which cytomegalovirus nucleoside analog dna polymerase inhibitor drugs treat aids-related opportunistic infections?
pharmaranks lists 3 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor products used for aids-related opportunistic infections, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.